United States · FDA National Drug Code directory
Docetaxel
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 25021-245_3897fe0d-2b9f-4be0-9076-9ccd693d4c86
- Product NDC
- 25021-245
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Docetaxel Anhydrous
- Labeler
- Sagent Pharmaceuticals
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170915
- Source listing expiry
- 20261231
Source-listed ingredients
- DOCETAXEL ANHYDROUS — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (25021-245-01) / 1 mL in 1 VIAL · 25021-245-01
- 1 VIAL in 1 CARTON (25021-245-04) / 4 mL in 1 VIAL · 25021-245-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →